ANTIMICROBIAL USE AND RESISTANCE: SURVEY OF KNOWLEDGE AND AWARENESS OF GENERAL PUBLIC IN CHITTOOR DISTRICT
DOI:
https://doi.org/10.22159/ijcpr.2024v16i3.4070Keywords:
Antimicrobial resistance, Antibiotic usage, Drug resistance, Multidrug resistanceAbstract
Objective: Antimicrobial resistance (AMR) leads to increased morbidity and mortality. WHO identified AMR as great threat to human health. India with highest bacterial disease burden in the world has rampant antibiotic usage. Natural phenomenon AMR is accelerated by the misuse and overuse of antibiotics. The responsibility of proper usage lies with both the prescribers and general public. Ecological, epidemiological, cultural and socioeconomic factors influence AMR. This study aims to enhance understanding of current public awareness and common behaviors related to antimicrobials, their use and AMR.
Methods: Descriptive closed-questionnaire-based face-to-face survey was conducted between January to March 2022 among 400 attendants of patients visiting the tertiary care hospital at Tirupati, Chittoor District. Residents aged>18 y were included; health care providers excluded. Data was collected using WHO questionnaire consisting of two parts.
Results: There is widespread antibiotic usage-70% of participants used at least once in past 6 mo. Many respondents were mistaken that head ache (42%) and cold (38%) require antibiotics. Only 66% of respondents knew to take full course of antibiotics. 26% of respondents never heard of antibiotic resistance terminology. 51% of participants had no idea that antibiotic-resistant bacteria can spread among persons. All the respondents agreed that regular hand washing is helpful.
Conclusion: Huge knowledge gaps were found along with various misconceptions and misunderstandings in the public. It is imperative to address these gaps as soon as possible to save the potency of available antibiotics. Reasons for misconceptions and ways to dispel them need further studies.
Downloads
References
World Health Organization. Antibiotic resistance: multi-country public awareness survey. World Health Organization; 2015. Available from: https://apps.who.int/iris/handle/10665/194460 [Last accessed on 24 Jan 2023]
Ganguly NK, Arora NK, Chandy SJ, Fairoze MN, Gill JP, Gupta U. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res. 2011;134(3):281-94, PMID 21985810.
WHO. Antimicrobial resistance: no action today, no cure tomorrow; 2011. World Health Organization. Available from: https://www.who.int>WHD_20110407 [Last accessed on 18 Mar 2023]
Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med. 2012;366(11):1028-37. doi: 10.1056/NEJMcp1104429, PMID 22417256.
Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:f1493. doi: 10.1136/bmj.f1493, PMID 23479660.
So AD, Ruiz Esparza Q, Gupta N, Cars O. 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards. BMJ. 2012;344:e1782. doi: 10.1136/bmj.e1782, PMID 22491076.
Cormican M, Vellinga A. Existing classes of antibiotics are probably the best we will ever have. BMJ. 2012;344:e3369. doi: 10.1136/bmj.e3369, PMID 22589509.
Courvalin P. Predictable and unpredictable evolution of antibiotic resistance. J Intern Med. 2008;264(1):4-16. doi: 10.1111/j.1365-2796.2008.01940.x, PMID 18397243.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84. doi: 10.1038/nrmicro3432, PMID 25853778.
Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653-60. doi: 10.1038/nrurol.2010.190, PMID 21139641.
Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329(18):1328-34. doi: 10.1056/NEJM199310283291808, PMID 8413414.
Published
How to Cite
Issue
Section
Copyright (c) 2024 PRASANNA LAKSHMI KAKARLA, PEDAPATIKASTURI, NELLORE SRIVANI, P. PRAKASH BABU
This work is licensed under a Creative Commons Attribution 4.0 International License.